Nutraforia LLC – Trademark Portfolio
Entity Type: 16
Nutraforia LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DR. SIEGAL'S. The owner is based in N. Bethesda, MD.
11810 Grand Park Avenue, Ste 500
N. Bethesda, MD 20852
Showing of trademarks Trademarks
Trademark Classifications
Nutraforia LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Frequently Asked Questions
How many trademarks does Nutraforia LLC have?
Nutraforia LLC has 8 U.S. trademarks filed with the USPTO. Of these, 1 registered, 7 abandoned.
What trademark classes does Nutraforia LLC file in?
Nutraforia LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods), Class 3 (Cosmetics & Cleaning), Class 29 (Meats & Processed Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Nutraforia LLC's most well-known trademarks?
Nutraforia LLC's registered trademark portfolio includes well-known marks such as DR. SIEGAL'S. These are among 1 currently registered trademark in the portfolio.
What is Nutraforia LLC's trademark registration success rate?
Nutraforia LLC has a 13% trademark registration rate, with 1 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.